Susana Monge

Carlos III Institute of Health - Communicable Diseases Department

Madrid

Spain

SCHOLARLY PAPERS

3

DOWNLOADS

981

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

The Effectiveness of mRNA Vaccine Boosters for Laboratory-Confirmed COVID-19 During a Period of Predominance of the Omicron Variant of SARS-CoV-2

Number of pages: 26 Posted: 15 Feb 2022
Carlos III Institute of Health - Communicable Diseases Department, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid Ministry of Health - Vaccines Division, Carlos III Institute of Health - Communicable Diseases Department, Madrid Ministry of Health - Centre for the Coordination of Health Alerts and Emergencies, Madrid Ministry of Health - Vaccines Division, Spanish Agency for Medicines and Medical Devices (AEMPS), Carlos III Institute of Health - Communicable Diseases Department and Harvard University - CAUSALab
Downloads 784 (64,404)

Abstract:

Loading...

Covid-19, SARS-CoV-2, Omicron, vaccines, effectiveness, Pfizer, Moderna

2.

Nirsevimab Effectiveness Against Rsv Hospital Admission in Children Under 1 Year of Age: A Spanish Population-Based Case Control Study

Number of pages: 28 Posted: 15 Aug 2024
Carlos III Institute of Health, Madrid Ministry of Health - Vaccines Division, Regional University Hospital – IBIMA, Consejería de Sanidad - Dirección General de Salud Pública, Subdirectorate of Epidemiology and Public Health Surveillance, Subdirectorate of Epidemiology and Public Health Surveillance, Consejería de Sanidad - Dirección General de Salud Pública, Health Services Research Network in Chronic Diseases (REDISSEC), Department of Health, Department of Health, Generalitat de Catalunya, Generalitat de Catalunya - Department of Health, Consejería de Sanidad - Dirección General de Salud Pública, Madrid Ministry of Health - General Directorate of Public Health, Public Health Directorate, Public Health Directorate, Canary Islands Health Service, Canary Islands Health Service, Public Health Directorate, Public Health Directorate, Madrid Ministry of Health - General Directorate of Public Health, Madrid Ministry of Health - General Directorate of Public Health, Hospital Universitari Son Espases, Hospital Universitari Son Espases, Madrid Ministry of Health - General Directorate of Public Health, Madrid Ministry of Health - General Directorate of Public Health, Consejería de Sanidad - Dirección General de Salud Pública, Consejería de Sanidad - Dirección General de Salud Pública, Instituto de Salud Pública y Laboral de Navarra, Consejería de Sanidad - Dirección General de Salud Pública, Consejería de Sanidad - Dirección General de Salud Pública, Consejería de Sanidad - Dirección General de Salud Pública, Consejería de Sanidad - Dirección General de Salud Pública, Consejería de Sanidad - Dirección General de Salud Pública, University Hospital of Melilla, University Hospital of Melilla, Consejería de Sanidad - Dirección General de Salud Pública, Consejería de Sanidad - Dirección General de Salud Pública, University Hospital of Ceuta, University Hospital of Ceuta, Carlos III Institute of Health - National Center for Epidemiology, Consejería de Sanidad - Dirección General de Salud Pública, Carlos III Health Institute and Carlos III Institute of Health - Communicable Diseases Department
Downloads 163 (361,781)

Abstract:

Loading...

Respiratory Syncytial Virus, Hospitalization, Nirsevimab, effectiveness, Observational Study.

3.

The Potential Bias Introduced into COVID-19 Vaccine Effectiveness Studies at Primary Care Level Due to the Availability of SARS-CoV-2 Tests in the General Population

Number of pages: 28 Posted: 12 Nov 2024
Epiconcept, Epiconcept, Carlos III Institute of Health - Communicable Diseases Department, National Institute for Public Health and the Environment (RIVM), Semmelweis University, National Institute of Health Doutor Ricardo Jorge, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Consejería de Sanidad - Dirección General de Salud Pública, Robert Koch Institute - Department for Infectious Disease Epidemiology, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Health Service Executive, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, NIVEL (Netherlands Institute for Health Services Research), Semmelweis University, National Health Institute Doutor Ricardo Jorge (INSA) - National Influenza Reference Laboratory, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Consejería de Sanidad - Dirección General de Salud Pública, Robert Koch Institute, Université Paris Saclay, Health Service Executive, Instituto de Salud Pública y Laboral de Navarra, National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM), European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 34 (881,326)

Abstract:

Loading...

COVID-19, Vaccine effectiveness, Test-negative design, Self-test, Bias, Directed acyclic graph, Simulation